Can we list all the available ( open source and commercial) parallel (written using MPI / Map Reduce etc) bioinformatics tools. It can include tools that cover both secondary and tertiary analysis i,e from Assembly to Annotation to SNP discover etc. Thank you.
Unconfigured Ad
Collapse
X
-
Where do I start with this Map Reduce fad and is it as bad as Web 2.0, which is as exciting as my grandmother finding out about the "any key" concept?Originally posted by geschickten View PostCan we list all the available ( open source and commercial) parallel (written using MPI / Map Reduce etc) bioinformatics tools. It can include tools that cover both secondary and tertiary analysis i,e from Assembly to Annotation to SNP discover etc. Thank you.
Map Reduce is a simple model that has been implicit in the design and workflow of parallel processes some time. Most short read aligners can be used in a Map Reduce model, and should be included. For example, you split the reads in to N chunks (usually while converting the Illumina/Solid/ect. input files to FASTQ), you run for each chunk in parallel using an instance of the mapping tool (typically implemented in a multithreaded fashion to take advantage of shared memory), and then merge the results (using maq merge or samtools merge etc.). This is clearly obeying the map reduce model. In fact, programs like BFAST actually come with pipeline scripts to operate in such a model using SGE/PBS schedulers.
Specific computer clusters like hadoop have APIs (say in Java) that help with the map reduce model, but is lacking high performance computing since most code is written in C.
My 1.5 cents (recession).
Comment
-
-
Yes the MapReduce model in and of itself is nothing new. But the availability of cloud services like AWS EC2 and software like Hadoop have made it that much more accessible to those who aren't C gurus and don't want to deal with the likes of sockets, locks, and other hassles of multithreaded processing. Hadoop can work on much less expensive hardware and can scale a lot more easily (as far as the programmer/end user is concerned). And in the end, if tuned correctly (Hadoop MR is much easier to tune than C code), the ability to scale will outweigh the supposed performance penalty of Java vs. C (which, I might add is a dinosaur of a concept and doesn't hold as true anymore).
Comment
-
Latest Articles
Collapse
-
by SEQadmin2
Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.
The systematic characterization of the human proteome has...-
Channel: Articles
07-20-2026, 11:48 AM -
-
by SEQadmin2
Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
...-
Channel: Articles
07-09-2026, 11:10 AM -
-
by SEQadmin2
Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.
There is no single reason why many patients don’t respond to treatment as expected. Cancer is...-
Channel: Articles
07-08-2026, 05:17 AM -
ad_right_rmr
Collapse
News
Collapse
| Topics | Statistics | Last Post | ||
|---|---|---|---|---|
|
Started by SEQadmin2, 07-20-2026, 11:10 AM
|
0 responses
14 views
0 reactions
|
Last Post
by SEQadmin2
07-20-2026, 11:10 AM
|
||
|
Started by SEQadmin2, 07-13-2026, 10:26 AM
|
0 responses
31 views
0 reactions
|
Last Post
by SEQadmin2
07-13-2026, 10:26 AM
|
||
|
Started by SEQadmin2, 07-09-2026, 10:04 AM
|
0 responses
42 views
0 reactions
|
Last Post
by SEQadmin2
07-09-2026, 10:04 AM
|
||
|
Started by SEQadmin2, 07-08-2026, 10:08 AM
|
0 responses
28 views
0 reactions
|
Last Post
by SEQadmin2
07-08-2026, 10:08 AM
|
Comment